The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Breast cancer risk factors
Open accessAbstract
Breast cancer is the most frequently diagnosed neoplastic disease in women around menopause often leading to a significant reduction of these women's ability to function normally in everyday life. The increased breast cancer incidence observed in epidemiological studies in a group of women actively participating in social and professional life implicates the necessity of conducting multidirectional studies in order to identify risk factors associated with the occurrence of this type of neoplasm. Taking the possibility of influencing the neoplastic transformation process in individuals as a criterion, all the risk factors initiating the process can be divided into two groups. The first group would include inherent factors such as age, sex, race, genetic makeup promoting familial occurrence of the neoplastic disease or the occurrence of benign proliferative lesions of the mammary gland. They all constitute independent parameters and do not undergo simple modification in the course of an individual's life. The second group would include extrinsic factors conditioned by lifestyle, diet or long-term medical intervention such as using oral hormonal contraceptives or hormonal replacement therapy and their influence on the neoplastic process may be modified to a certain degree. Identification of modifiable factors may contribute to development of prevention strategies decreasing breast cancer incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Benign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044383 · Cited by 938
Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9523-x · Cited by 693
Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., Saunders, C., Roche, N., Mansel, R. E., von Minckwitz, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62292-8 · Cited by 590
Oral Contraceptives and the Risk of Breast Cancer
Marchbanks, P. A., McDonald, J. A., Wilson, H. G., Folger, S. G., Mandel, M. G., Daling, J. R., Bernstein, L., Malone, K. E., Ursin, G., Strom, B. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013202 · Cited by 532
Oral contraceptives and the risk of breast cancer*
(2003) · Obstetrics & Gynecology · doi:10.1097/00006250-200304000-00031 · Cited by 431
Light alcohol drinking and cancer: a meta-analysis
Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds337 · Cited by 424
Hsieh, C., Trichopoulos, D., Katsouyanni, K., & Yuasa, S. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460508 · Cited by 421
Kaaks, R., Berrino, F., Key, T., Rinaldi, S., Dossus, L., Biessy, C., Secreto, G., Amiano, P., Bingham, S., Boeing, H., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji132 · Cited by 420
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
Eliassen, A. H., Missmer, S. A., Tworoger, S. S., Spiegelman, D., Barbieri, R. L., Dowsett, M., & Hankinson, S. E. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj376 · Cited by 385
Genetic susceptibility to breast cancer
Mavaddat, N., Antoniou, A. C., Easton, D. F., & Garcia-Closas, M. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.011 · Cited by 375
Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention
Couch, F. J., Nathanson, K. L., & Offit, K. (2014) · Science · doi:10.1126/science.1251827 · Cited by 342
Epidemiology of Male Breast Cancer
Weiss, J. R., Moysich, K. B., & Swede, H. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.20.14.1 · Cited by 328
Visvanathan, K., Hurley, P., Bantug, E., Brown, P., Col, N. F., Cuzick, J., Davidson, N. E., DeCensi, A., Fabian, C., Ford, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3122 · Cited by 307
Physical Activity and Breast Cancer Prevention
Lynch, B. M., Neilson, H. K., & Friedenreich, C. M. (2010) · Recent Results in Cancer Research · doi:10.1007/978-3-642-04231-7_2 · Cited by 282
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
Young, Sr., Pilarski, R. T., Donenberg, T., Shapiro, C., Hammond, L. S., Miller, J., Brooks, K. A., Cohen, S., Tenenholz, B., DeSai, D., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-86 · Cited by 273
Apter, D., Reinilä, M., & Vihko, R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440506 · Cited by 256
McTiernan, A., Martin, C. F., Peck, J. D., Aragaki, A. K., Chlebowski, R. T., Pisano, E. D., Wang, C. Y., Brunner, R. L., Johnson, K. C., Manson, J. E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji279 · Cited by 254
Thiebaut, A. C. M., Kipnis, V., Chang, S.-C., Subar, A. F., Thompson, F. E., Rosenberg, P. S., Hollenbeck, A. R., Leitzmann, M., & Schatzkin, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk094 · Cited by 216
Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women
Hunter, D. J., Colditz, G. A., Hankinson, S. E., Malspeis, S., Spiegelman, D., Chen, W., Stampfer, M. J., & Willett, W. C. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0747 · Cited by 210
Adjuvant systemic therapy for male breast carcinoma
Giordano, S. H., Perkins, G. H., Broglio, K., Garcia, S. G., Middleton, L. P., Buzdar, A. U., & Hortobagyi, G. N. (2005) · Cancer · doi:10.1002/cncr.21526 · Cited by 200
Ban, K. A., & Godellas, C. V. (2014) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.03.011 · Cited by 185
Bauer, S. R., Hankinson, S. E., Bertone-Johnson, E. R., & Ding, E. L. (2013) · Medicine · doi:10.1097/md.0b013e3182943bc2 · Cited by 183
Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1907 · Cited by 176
Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women
Tamimi, R. M., Hankinson, S. E., Chen, W. Y., ROSNER, B. A., & Colditz, G. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1483 · Cited by 151
Diet and risk for breast cancer recurrence and survival
Saxe, G. A., Rock, C. L., Wicha, M. S., & Schottenfeld, D. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006190820231 · Cited by 145
Prentice, R. L., Chlebowski, R. T., Stefanick, M. L., Manson, J. E., Langer, R. D., Pettinger, M. B., Hendrix, S. L., Hubbell, F. A., Kooperberg, C. L., Kuller, L. H., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn090 · Cited by 135
Banks, E., REEVES, G. K., Beral, V., Bull, D., Crossley, B., Simmonds, M., Hilton, E., Bailey, S., Barrett, N. K., Briers, P., et al. (2004) · BMJ · doi:10.1136/bmj.329.7464.477 · Cited by 123
Comparison of Male and Female Breast Cancer Incidence Trends, Tumor Characteristics, and Survival
Hill, T. D., Khamis, H. J., Tyczynski, J. E., & Berkel, H. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2005.01.001 · Cited by 122
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000093674.44946.d6 · Cited by 119
Gnerlich, J. L., Deshpande, A. D., Jeffe, D. B., Seelam, S., Kimbuende, E., & Margenthaler, J. A. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1468-3 · Cited by 109
Farhat, G. N., Cummings, S. R., Chlebowski, R. T., Parimi, N., Cauley, J. A., Rohan, T. E., Huang, A. J., Vitolins, M. Z., Hubbell, F. A., Manson, J. E., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr031 · Cited by 108
Oral contraceptive formulation and risk of breast cancer
Marchbanks, P. A., Curtis, K. M., Mandel, M. G., Wilson, H. G., Jeng, G. T., Folger, S. G., McDonald, J. A., Daling, J. R., Bernstein, L., Malone, K. E., et al. (2011) · Contraception · doi:10.1016/j.contraception.2011.08.007 · Cited by 85
Fortner, R. T., Eliassen, A. H., Spiegelman, D. L., Willett, W. C., Barbieri, R. L., & Hankinson, S. E. (2013) · Breast Cancer Research · doi:10.1186/bcr3394 · Cited by 82
Counseling for male BRCA mutation carriers – a review
Mohamad, H., & Apffelstaedt, J. (2008) · The Breast · doi:10.1016/j.breast.2008.05.001 · Cited by 80
McTiernan, A., Chlebowski, R. T., Martin, C. F., Peck, J. D., Aragaki, A. K., Pisano, E. D., Wang, C. Y., Johnson, K., Manson, J. E., Wallace, R. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7166 · Cited by 64
Male breast cancer: An update in diagnosis, treatment and molecular profiling
Onami, S. H., Ozaki, M., Mortimer, J. E., & Pal, S. K. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.012 · Cited by 58
Hormone therapy, mammographic density, and breast cancer risk
Martin, L. J., Minkin, S., & Boyd, N. F. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.07.009 · Cited by 55
Francken, A. B., Schouten, P. C., Bleiker, E. M. A., Linn, S. C., & Rutgers, E. J. T. (2013) · The Breast · doi:10.1016/j.breast.2013.07.045 · Cited by 34
Fournier, A., Berrino, F., & Clavel‐Chapelon, F. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9604-x · Cited by 33
Genetic testing and familial implications in breast-ovarian cancer families
Oosterwijk, J. C., de Vries, J., Mourits, M. J. E., & de Bock, G. H. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.002 · Cited by 30
Benign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000489578.68399.d7 · Cited by 26
Prognostic Factors in Node-Negative Male Breast Cancer
Avisar, E., McParland, E., Dicostanzo, D. P., & Axelrod, D. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.046 · Cited by 21
Breast cancer risk: perception versus reality
Westhoff, C. L. (1999) · Contraception · doi:10.1016/s0010-7824(98)00134-6 · Cited by 14
Brenner, R. J. (2010) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2010.10.049 · Cited by 4
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Primary and secondary prevention of breast cancer
Kolak, A., Kamińska, M., Sygit, K., Budny, A., Surdyka, D., Kukiełka-Budny, B., & Burdan, F. (2017) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/75943 · Cited by 350
Self-citationRANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
Infante, M., Fabi, A., Cognetti, F., Gorini, S., Caprio, M., & Fabbri, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1001-2 · Cited by 180
Metadata
- Authors
- Kamińska, M., Ciszewski, T., Łopacka-Szatan, K., Miotła, P., & Starosławska, E.
- Venue
- Menopausal Review
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2015
- Volume
- 3
- Issue
- 3
- Pages
- 196-202
- ISSN
- 1643-8876 (ISSN-L)
- OpenAlex
- W2309472119
- Cited by
- 383
- References
- 51
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.